The Global Burden of Disease Study 2015 (GBD 2015), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors at the global, regional, national, territorial, and, for a subset of countries, subnational level.
As part of this study, the health burden associated with systolic blood pressure (SBP) ≥ 110-115 mm HG and SBP ≥ 140 mm HG (hypertension) was analyzed. Estimates for deaths, years of life lost (YLL), years lived with disability (YLDs), and disability-adjusted life year (DALYs) attributable to SBP ≥ 110-115 mm HG (high systolic blood pressure) by age and sex for 21 regions, 195 countries and territories and select subnational units for 1990-2015 (quinquennial) are available from the GBD Results Tool.
Results of the study from 154 countries that included 8.69 million participants showed that between 1990 and 2015 the rate of SBP of at least 110 to 115 mm Hg increased from 73119 to 81373 per 100000 persons, and SBP of 140 mm Hg or higher increased from 17 307 to 20 526 per 100 000 persons. The estimated rate of annual deaths associated with SBP of at least 110 to 115 mm Hg increased from 135.6 to 145.2 per 100 000 persons, and for SBP of 140 mm Hg or higher increased from 97.9 to 106.3 per 100 000 persons. Over the past 25 years, the number of individuals with worldwide SBP levels of at least 110 to 115 mm Hg and of 140 mm Hg or higher and the estimated associated deaths have increased substantially.
This study is published in JAMA in January 2017 in “Global Burden of Hypertension and Systolic Blood Pressure of at least 110 to 115 mm HG, 1990-2015.”